|
Cut the Cost of Doing Business
| 
SoCalBio
Partners With FedEx to Offer up to 35% Discounts on Shipping Services
to SoCalBio Members Through the BioBusiness Solutions Program... Learn more | |
|
Thanks to SoCalBio Weekly Update Sponsor
|
Recommended Events
September 7 - 9 Boston, MA 
September 26- 28
Washington DC 
October 3-5
Pasadena, CA
|
Join SoCalBio
Join
SoCalBio leaders to promote the biotech and device industries in the
Greater Los Angeles Metro Area for job creation and overall economic
growth.
When you join, you will enjoy significant discounts
on products and services from lab and office supplies to insurance and
scientific publications. Discounts are exclusive to SoCalBio member
companies in Los Angeles, Orange, Ventura, Santa Barbara, Riverside and
San Bernardino counties... Click here to see why
|  |
| Thanks to SoCalBio Media Partners
|
|
|
|
Coming Next Week
| |
BIO's Chief James Greenwood Meets with SoCalBio Members on August 18 to Discuss BIO's
New 5-Year Plan
 During
his first visit to Los Angeles since assuming BIO's leadership
position, James Greenwood (photo right), Former Congressman and now
President & CEO of the Biotechnology Industry Organization (BIO),
will meet with executives representing emerging biotech companies in
the Greater Los Angeles/Orange County region to discuss BIO's new policy
agenda. This agenda is embodied in a new 5-year plan designed to enable
the biotechnology industry to fulfill its promise to help, heal, fuel,
and feed the world ... Access BIO's Plan
|
| RSVP Now | |
SoCalBio Networking Forum in Ventura County
Micro-Manufacturing the
Next-Generation Medical Devices
Thursday, August 25, 2011
4:00 PM - 7:00 PM (PT)
Westlake Village Inn
31943 Agoura Road, Westlake Village, CA 91361
|
|
Coming in November
| |
|
|
Welcome, New SoCalBio Member
| |
Zickfeld Associates (Los Angeles)
Zickfeld Associates
is a boutique advisory firm providing the life sciences, medical
device, and technology industries with business strategy and business
development expertise and advice.
National
Green Gas LLC (Indio)
National Green Gas
is a new company in Southern California that has a recently approved
technology for treating all biomedical waste types without incineration.
The process is approved by the State Dept of Public Health and is less
expensive, more efficient, and greener and achieves the ultimate goal
of landfill diversion ... Read more
Avita Medical (Northridge)
Avita Medical
develops spray-on skin processes to treat skin trauma, including burns.
The Company markets its skin products under the names CellSpray and
ReCell. According to Avita, ReCell has been approved for marketing and
sale in Europe, Canada and Australia... Click here for more info
Amicrobe (Pasadena)
Amicrobe, Inc.
uses advanced synthetic biopolymer chemistry to create materials that
can prevent and treat infections. These materials can be designed to
have broad-based antimicrobial activities as well as to support wound
healing... Learn more
|
| New Renal Stent System | |
The FDA Approves Abbott Vascular's RX Herculink Elite Renal Stent System
|  The
Temecula-based Abbott Vascular got FDA nod to market its RX Herculink
Elite Renal Stent System. This stent and its delivery system are
approved for patients with atherosclerotic disease of the renal arteries
who have had sub-optimal balloon angioplasty of a de novo or
re-stenosed lesion. Approval has been restricted to particular lesion
sizes, location, and vessel diameter. Sale and distribution are further
limited to specific training sites or experienced practitioners ... See FDA approval letter |
| New Financing | |
Vessix Vascular Completes $23 Million Financing
|  The
Laguna Hills-based Vessix Vascular, Inc. (formerly known as Minnow
Medical, Inc.), a developer of novel percutaneous radiofrequency (RF)
balloon catheter technology, announced the closing of a $23 million
Series B preferred stock financing. The lead investor in the financing
round was Edmond de Rothschild Investment Partners (EdRIP) of Paris,
France. Also participating in the financing was NY-based OrbiMed
Advisors, CDF Dinova Venture Partners of Hong Kong along with existing
investors NeoMed Management and Christopher Weil & Company ... Read more
Ellipse Technologies Inc. Closes a $17.6 Million Round of Financing  The
Irvine-based developer of devices for orthopedic deformity prevention
and management, has raised $17.6 million in Series C funding. HBM BioVentures and BioStar Ventures were joined by return backers Wexford Capital and the MedFocus Funds ... Read more
|
Ischemic Stroke
| |
MindFrame Inc.'s LP Device Successfully Utilized in First-in-Human Procedure for the Treatment of Ischemic Stroke
|  The
Irvine-based MindFrame Inc. announced the successful first-in-human
procedures of the MindFrame Capture LP low profile device for the
treatment of patients suffering from ischemic stroke at Katherinen
Hospital in Stuttgart, Germany. "I am excited about the first cases,
which are the result of the ability of our scientists and engineers to
rapidly respond to the needs of clinicians," says Ken Charhut (photo
right), president and CEO of MindFrame Inc. "This milestone underscores
our commitment to delivering truly innovative technologies to clinicians
around the world in order to provide outstanding patient care" ... Read more |
 |  |
| Patenting | |
ImmunoCellular Therapeutics Issued New Patent for Diagnosis and Treatment of Ovarian Cancer and Multiple Myeloma
 "We
are actively extending our intellectual property protection for the
treatment and detection of cancers," said Manish Singh, Ph.D. (photo
right) president and CEO of ImmunoCellular Therapeutics. "Strengthening
our patent portfolio will support the developmental efforts surrounding
our technology platforms and enhance our ability to license or partner
these platforms" ... Read more
| |
Inhaled Insulin
| |
MannKind Meets with the FDA Tomorrow (August 10) to Discuss Afrezza Trials Design
| | The
FDA told the Valencia-based MannKind in January that it would need to
run additional clinical trials to get marketing approval for Afrezza.
The meeting on August 10 is for the company and the agency to discuss
the design and goals of those trials. MannKind first asked the FDA to
approve Afrezza in March 2009, and was asked to provide more data... Read more |
People on the Move
| |
Cynvenio Biosystems Adds Amit Munshi and Simon Raab, Ph.D. to Its Board of Directors
 The
Westlake Village based developer of high performance cell isolation
technology for biomedical research and novel cancer diagnostics,
announced that Amit Munshi and Simon Raab, Ph.D. have joined its board
of directors. "We are very pleased to welcome Mr. Munshi and Dr. Raab to
the Board of Directors," said André de Fusco (photo right), Cynvenio's
chief executive officer. "These are exceptional individuals with proven
track records of success. Their experience will be invaluable as
Cynvenio enters its commercial growth stage" ... Read more
| |
Jobs Available
| |
Radient Pharmaceuticals (Tustin)
Gilead (San Dimas)
Maven Biotech (Pasadena)
IntriMed Technologies (Ventura)
Nanogea (Culver City)
|
|
| About SoCalBio |
 SoCalBio
membership links you to partners, contract manufacturers, regulatory
and legal experts, and policy makers. The organization's programs help
emerging biotech and medical device companies grow. Membership is
affordable -- as low as $500 -- and offers access to networking
opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
|
|
